Physician profile
Sanjeev Naresh Puri
NPI 1720304447
$3,540.96
in general payments reported to CMS, 2019-2025
25 companies · $562 in 2025
The $562 reported for 2025 was more than what a typical Surgery of The Hand (Plastic Surgery) provider received nationally (typical 2025 total: $312).
See the full distribution for Surgery of the Hand (Plastic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $664 · 2021: $315 · 2022: $234 · 2023: $1,145 · 2024: $420 · 2025: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,781 · Long Term Medical Supply Or Device Loan: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,780.78 |
| Long Term Medical Supply Or Device Loan | $346.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $957.16 | 2019-2024 | Integra, Neuragen, Integra Dermal Regeneration Template |
| Tela Bio, INC. | $558.32 | 2021-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Musculoskeletal Transplant Foundation INC. | $516.28 | 2019-2024 | |
| Aroa Biosurgery Incorporated | $177.56 | 2025 | |
| Tactile Systems Technology INC | $144.63 | 2020-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Medtronic, INC. | $139.49 | 2025 | Transorb |
| Portola Pharmaceuticals, LLC | $123.24 | 2020 | |
| Axogen | $118.71 | 2019-2021 | |
| Smith+Nephew, INC. | $96.30 | 2023 | Acticoat 4" X 4", Pico, Pico 7 |
| Mentor Worldwide LLC | $70.83 | 2019-2025 | Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Solventum Corporation | $66.49 | 2024-2025 | Activ.A.C., V.A.C.Instill |
| Lilly USA, LLC | $66.13 | 2024 | Zepbound |
| Biotissue Holdings INC. | $62.53 | 2024 | |
| Polynovo North America LLC | $59.95 | 2025 | Novosorb Btm |
| Stryker Corporation | $55.75 | 2021-2024 | Na |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tei Biosciences INC | $54.49 | 2019 | |
| Acera Surgical, INC. | $46.64 | 2024-2025 | Restrata Wound Matrix |
| Kci USA, INC. | $46.54 | 2019-2023 | V.A.C. Veraflo, Activ.A.C., V.A.C. Dermatac |
| Checkpoint Surgical, INC | $35.45 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $30.83 | 2025 | Austedo Xr |
| Avita Medical Americas, LLC | $29.70 | 2025 | Permeaderm, Cohealyx, Recell |
| Ethicon US, LLC | $24.53 | 2021 | |
| Xeris Pharmaceuticals, INC. | $23.96 | 2023 | Gvoke Hypopen |
| Abbvie INC. | $20.57 | 2025 | |
| Sientra, INC. | $14.88 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjeev Puri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.